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My name is Sarah Bishop and I am a pursuing a Bachelor of Science degree in both
chemistry and biology at Ouachita Baptist University. Part of my degree is obtaining research
hours for both chemistry and biology. In the summer of2013, I participated in research at the
University of Arkansas for Medical Sciences (UAMS) College of Pharmacy Department of
Pharmaceutical Sciences under the INBRE Summer Research Fellowship. As a result of my
research experience I produced this thesis is addressed to future and current science students at
OBU and science students in general. This thesis addresses how my idea of research has
changed before and after this experience and how I have changed as a student and as a person.
Please enjoy.
Pre-research ideas:
I thought I would be wearing a lab coat and goggles, sitting at a clean white lab bench
and be in a chemistry setting with bunsen burners. I thought I would report to my mentor the
results of the tests I ran and then go back to work. I thought I would have privacy and be a
professional ... a chemist. I know it sounds as if I viewed myself as a very capable woman.
After all, I did just come out of the class Experimental Techniques, where we used practically
every instrument available in the chemistry department to analyze compounds we synthesized. I
thought I knew everything about working in a lab. And oh, how I was wrong. Just because I
would make A's on my paper and knew how to work the instruments at OBU (well, at least I
thought I knew how to run the instruments) did not mean I knew how to work the instruments at
UAMS, or would even be allowed to. Something I learned at UAMS was that I would actually
have to understand, truly understand, and truly grasp, the concept of my research, not be able to
just put words on a paper and get fluorescence results back, but truly understand what the
fluorescence meant.
When asked a question, there were no other students I could hide behind. No more "sit
quietly, head down and wait until someone else says something," because I didn't want to look
like a fool. No. It was me and Dr. Liu. It was me answering questions, or at least giving an
answer, and hoping it was right. Me feeling dumb at times for not remembering anatomy and for
feeling like I was embarrassing my school and professors for passing me in the class when I
could not remember the material now. Me feeling embarrassed and ashamed telling Dr. Liu I
wanted to become a pharmacist when I could not remember some important equilibriums in the
blood stream. I felt like crying some times when asked a math question for dilutions and I felt it
was an eternity before I answered. Where was my pen and paper and, for goodness sakes, my
calculator?! No, Dr. Liu made me give an answer on the spot and made me toughen my skin on
the spot.
Please don't get me wrong, Dr. Liu was a very kind and patient man. He encouraged
questions and understood I could not know everything. He only had one rule: a student is not to
be blamed, until they are taught the lesson. Once they are told the correct answer, it is then their
responsibility to remember it.
The INBRE Fellowship was a 10-week program which consisted of research, a final
paper, and a presentation. Dr. Liu and I spent the first two days discussing the background in the
research and how to fit a project into ten weeks. I know that may sound like some time, but ten
weeks was broken down into one week to plan, six weeks to run the experiment and collect data,

one week to prepare a powerpoint for presentation, one week to practice and present, and then
the final week to clean up in lab. Practically, only six weeks for lab work.
As time went on, I began to grasp the concepts. I began to be not as afraid to give the
answers to the questions, and started to get answers right! I started to form a trusting relationship
with my mentor. I felt more on his level, not professionally or academically, but where I could
have a conversation with him about the research instead of being told about the research.
For the most of the lab time, Dr. Liu would be watching over my shoulder. I would be
able to do most of the work myself such as changing the water for the mice, cleaning their cages
and making solutions, but he would do the ultrasound and termination of the mice at the end. I
was never alone and at first felt insulted, because I thought he assumed I couldn't do anything,
but that was just rude of me. It was his lab and he wanted to make sure I didn't waste any of his
materials. He wanted to ensure that the solutions were properly made and to be honest, I am glad
he was there, because I would probably have messed up ifhe wasn't. Dr. Liu also showed me
some tricks to help better my lab technique.
Over the six weeks of research, I ran tests, collected data and made conclusions. The
following describes my lab procedures and contains the results of the experiments. Preceding
this paragraph was what I thought of research before I started work. Following my research, my
views have changed and my appreciation has greatly increased of research and researchers.
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Abstract
The bark of Terminalia arjuna (TA), a tropical tree, has been used in Ayurvedic
medicine for treatment of cardiovascular disease. TA bark is known to contain various
antioxidants, and recently it has been suggested to enhance function of the normal heart as
an over-the-counter supplement in the USA. The mechanism underlying cardiac actions of
TA bark are unknown. Doxorubicin (DOX), a commonly-used anticancer drug, is known to
cause cardiotoxicity, a major concern in chemotherapy. The aim of this study is to
investigate whether aqueous extracts of TA bark (TAaq) protect the heart from DOX
treatment by counteracting the oxidative stress caused by DOX. H9c2 cells, a cell line
derived from the rat heart, were used for the in vitro study to examine cellular mechanis(s)
of actions of TAaq. Echocardiography was used to monitor cardiac function of mice with
and without co-treatment of DOX and TAaq· Our results showed that treatments of H9c2
cells with DOX (1 J.lM) for 24 hr caused an increase in superoxide production and damage
to the growth network which were attenuated by co-treatment with TAaq (100 J.lg/ml). Our
in vivo data showed that TAaq (50-100 f.1g/ml in drinking water) prevented the decrease in
left ventricle function caused by multiple weekly treatments with DOX. These preliminary
data suggest that TAaq protects the heart in part from oxidative stress caused by DOX.

Introduction
Doxorubicin (DOX), a commonly-used anticancer drug, is known to cause cardiotoxicity
likely via increased oxidative stress of cardiac myocytes (1 ). The cardiotoxicity of DOX is a
major concern in cancer chemotherapy. The bark of Terminalia arjuna (TA), a tropical tree, has
been used in Ayurvedic medicine for treatment of cardiovascular disease for centuries. TA bark is
known to contain active organic constituents such as tannins, triterpenoid saponins, flavonoids,
gallic acid, ellagic acid, oligomeric proanthocyanidins, and phytosterols, and recently it has been
suggested to enhance function of the normal heart as an over-the counter supplement in the USA.
However, the mechanism underlying cardiac actions of TA bark are unknown. The aim of this
study is to investigate whether aqueous extracts of TA bark (TAaq) protect the heart from DOX
treatment by counteracting the oxidative stress caused by DOX.

Experimental Procedures
TAaq bark preparations

The aqueous extracts of TA bark were prepared as described previously (2). Briefly,
1.005g of pulverized crude TA bark was added to 50 mL of boiling milli-Q water and continued
to boil for 15-20 minutes. After centrifugation at 6000 x g for 2 minutes, the supernatant
(decoction) was collected and filtered through a 0.22 ~ filter. The concentration and percent
yield for the TAaq stock solution was 4.5 mg/ml and 20%, respectively.
Growth medium

H9c2 cells (American Type Culture Collection® CRL-1446™), a commonly used cell
model derived from rat heart, were cultured in Dulbecco's Modified Eagle's Medium (DMEM)
following ATCC instructions. Briefly, cells were thawed and maintained in high glucose DMEM
medium supplemented with 10% FBS growth medium in a T-25 culture flask incubated at 37°C.
After growing to approximately 70% confluence, cells were distributed to 24-well plates for
study.
Fluorescence microscopy

Two fluorescent dyes were used to detect the oxidative stress of H9c2 cells; one
superoxide-sensitive dihydroethidin (DHE) and mitochondria-sensitive MitoTracker®, both of
whose oxidized forms emit fluorescence detected at 580 nm (excitation at 535 nm). H9c2 cells
were treated with TAaq (100 J..lg/rnL) 20-30 min before DOX (1 J..tM) treatment and maintained in
a 5% COz incubator at 37°C for 2-24 hours. At 30-45 min before the termination ofDOX
treatments cells were incubated with DHE (3 J..lM) or MitoTracker® (0.1 J..lM) in the incubator at
37°C. At the end of experiments, dyes were washed off with Hepes-buffered salt solution. The
fluorescence images ofDHE and MitoTracker were acquired withAxioVision software using the
same exposure duration to yield sub-maximal intensity at the same magnification within each
individual experiment, and analyzed using NIH ImageJ.
Daily drinking water and DOX treatment

Four C57/BL6 mice were used for the in vivo experiment. Two of four C57/BL6 mice
received drinking water containing TAaq (50 or 100 J..lg/mL) for 4 days before DOX injection.
Water intake of each mouse was measured and recorded daily. Water was daily replaced with
freshly-made TA bark drinking water. One of the two C57/BL6 mice receiving drinking water
containing TA and one of the two C57/BL6 mice receiving drinking water not containing TAaq
received a weekly injection ofDOX (10 mg/kg body weight, i.p.) for two weeks. The other two
mice, one of which received drinking water containing TAaq and one receiving drinking water not
containing TAaq, received a weekly injection of the same volume of saline.
Echocardiography

Echocardiograms were obtained using a Vevo® 2100 high-resolution imaging system
(VisualSonics) specifically for the analysis of small animals. Briefly, the mouse was weighed
and anesthetized with isoflurane at 3% at 1 liter per minute (lpm) medical-grade air. Once the
mouse was unconscious, the mouse was quickly transferred and taped to a heated platform in a

dorsal recumbent position. The isoflurane was then reduced to 1%. Vital signs (heart rate,
respiration rate and body temperature) were monitored throughout the imaging.
The hair of the chest was removed using a chemical hair remover (Nair). Prewarmed ultrasound
gel (Aquasonic 100) was spread over the clean chest. A MS-550D probe was used to acquire
ultrasound images of the heart. The ultrasound examination for each mouse took less than
1 hour. After the examination, the mouse regained consciousness and was returned to its cage.
Echocardiography was performed weekly to assess the left ventricular function before, during,
and 2 weeks after 2-week treatments with DOX.
Histological examination

After termination of the mice, the heart was removed from the body and flushed through
the aorta with control HTBSS solution followed by 10% neutral buffered formalin. After being
blotted dry, the heart was weighed to determine the ratio of heart weight to body weight. The
heart of each mouse was then returned to the buffered formalin solution for 24 hours before
being embedded in paraffin. Each heart was cut into sections of 5-f..lm thickness which were
mounted on glass microscope slides. Histological analysis of the sections of each heart was
performed after a Gomori Trichome stain (performed by pathology core facility).

Results and Discussion
Attenuation ofDOX-induced superoxide production and cell damages by TAaq

Oxidative stress of H9c2 cells was assessed using superoxide-sensitive DHE staining of
cells treated with DOX and co-treated with TAaq for 24 hours. Figure 1 shows after 24 hours,
DOX ( 1 f..l.M) enhanced superoxide production (Figure 1C) compared with the control (Figure
1A) and TAaq alone (Figure 1B). DOX also reduced cell growth and connection and reduced the
cell number (Figure 1C). Cotreatment of DOX with TAaq significantly reduced the production of
superoxide and cell damage (Figure 1D). The quantitative analysis of relative superoxide
production induced by DOX and inhibition by TAaq is shown in Figure 2.
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Figure 1. Superoxide production was measured by DHE fluorescence in H9c2 cells treated with or
without DOX and co-treatment with or without TAaq for 24 hours.
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respectively. The measured parameters are shown in Table 1 and Figure 7. The cardiac function
of individual hearts at the 4th week was compared to that before pharmacological intervention (or
the baseline). During the period of 4 weeks, cardiac function did not significantly change in the
control and TAaq-treated mice. In contrast, there was more than a 20% decline in cardiac function
of the DOX-treated heart 2 weeks after termination ofDOX injection. The DOX-induced decline
in cardiac function was not observed in the mouse treated with TAaq prior to DOX injections.

Figure 7 shows that the cardiac function in control and TAaq-treated hearts remained
relatively constant during this 4-week experiment. One week after the 1st injection ofDOX, the
ejection fraction of the heart was transiently increased, possibly due to adaptive response of
cardiac function to DOX. However, the ejection fraction declined more than 20% 2 weeks after
termination ofDOX administration.
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Figure 7. Chronological monitor of function of the mouse heart in these 4 groups

This result was consistent with the clinical observation that cardiotoxicity is often observed a
certain period of time after termination of chemotherapy (1,3). In summary, the
echocardiographic (in vivo) data are consistent with the in vitro data, i.e. , TA aq prevented the
decline in cardiac function induced by DOX treatment.

Conclusion
Our data suggest thar L4aq exerts protective and therapeutic effects on DOX-induced
cardiotoxicity, likely resulting in part from its capability to reduce the mitochondrial oxidative
stress caused by DOX. Thus TAaq is of potential value in the clinic for cancer patients receiving
chemotherapy. Future studies will investigate detailed cellular mechanism(s) underlying the
cardiac protective action of TAaq and identify correspondent active components in TAaq.
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Post-research ideas:
What I considered, at the beginning of my research, annoying and added pressure with
Dr. Liu standing behind me, became enjoyable and needed. When I was alone in the lab, there
were times it was hard not to mess up and at times it could be lonely. At other times, I became
more comfortable in the lab and enjoyed the relaxation.
I thought people did research for their own personal gain. I know the reason for doing
research is to help others and to find a cure, but with the great discoveries come great fame and
great fortune ... Nobel Prize fortune. I mean, this is your career after all. You go through years
of school, so why don't you want recognition for your intellectual abilities and break-through
ideas? I thought you would want recognition, and I was right to a point. It wasn't so much
wanting to be published for personal gain, but for professional gain-professional gain to be able
to earn more grants, maintain and expand your lab space, hire lab technicians, and maintain your
job. I did not realize there are many research institutions with the motto "publish or perish."
Researchers need grants to provide the funding to buy the expensive antibodies, the expensive
chemicals, and pay for the expensive instruments to be used. Researchers need to be published
to show their research had meaningful results and to prove to organizations which provide grants
that the money they give will be well spent and will be furthering research.
My mentor, Dr. Liu, does research because it interests him and he wants to find a cure to
a problem facing patients. He wants to help people. While I am sure there are some exceptions,
as there seem to be in every situation in life, the people at UAMS all seemed to have heart, drive,
charisma, a purpose and goal for their work. Their research is their baby.
One day in lab, I was talking to Dr. Liu and we came to talk about one of his friends who
just found out she had breast cancer. One of the downfalls about being in science and cancer
research is that you know the statistics, the downsides of chemotherapy, and the long term effects
of treatment. Our project was examining how to lower the cardiotoxic effects of doxorubicin, a
commonly used anticancer drug. We were examining how the aqueous extracts of Terminalia
arjuna bark can protect the heart from doxorubicin-induced oxidative stress, which would cause
heart problems or heart failure 5- 15 years after treatment with doxorubicin.
Dr. Liu knows his friend could be treated with doxorubicin and knows the resulting
effects doxorubicin would have on her heart. One cannot be ignorant. However, there is a bright
side. Dr. Liu is researching a cure for this. Adding the aqueous extracts of the Terminalia arjuna
bark could prevent or delay the damage the doxorubicin causes on the heart. He is researching
something that could prevent people from having as many heart conditions due to treatment of
doxorubicin. His research could helping limit the worry cancer patients have about the side
effects the chemotherapy has on their heart and allow them to enjoy life.
The answer can lie in a few tests. It could be a simple fix: just consume TAaq and DOX at
the same time during chemotherapy. No worries, no problems, no fear of the future. A solution
was there. I was looking at it, working with it. Why was this not on the market? Why was
funding hard to get for this? Why? The answers facing so many problems with current
medicine, cancer and cardiovascular issues was right there. It is amazing how he could come up
with this hypothesis, how he could put these pieces together.
So, what was a main reason he had trouble finding funding? He didn't know what the
active compounds were in the TAaq. Before funding, organizations want to know what is in TAaq.
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Dr. Liu said he would need funding in order to be able to carry out the tests. He needed someone
to have faith in him that even though he didn't know what the TAaq was composed of, the
investment of money into tllls research could lead to promising results to the investigation of
TAaq and its interactions with DOX. However, the money from funding comes from government
dollars, tax dollars, your dollars. Therefore, just "giving away" the money on a leap of faith is
not encouraged. Furthermore, most analytical techniques and compounds are organic- our
solution is an aqueous solution. Organic and aqueous solutions separate out from one another
and many solvents used when analyzing organic compounds cannot be used to analyze aqueous
compounds. This was the problem facing Dr. Liu.
When I began this fellowship, I thought I understood research and I thought I gave
research its proper respect. I was wrong. My view of research has expanded and my
appreciation has elevated. We are surrounded by hundreds of people who stay in a lab half the
size of many classrooms, sometimes crammed with supplies and instruments and run a single test
multiple times in order to make sure results are conclusive. Sometimes the results of the tests are
not what one expected to see; sometimes you think you might have found a solution, but the tests
say you didn't so you have to try again.
Researchers do not give up. Researchers read countless scientific journals, articles and
papers which other researchers have written to try to use the information they found and combine
with their own to find an answer or make a discovery. Researchers are the ultimate treasure
hunters. The treasure they seek is a solution to the problem, whether that is fixing the side
effects of certain cancers, turning receptors back on to prevent cancer or whatever the solution
may be. They obtain their clues by reading, testing and taking chances. There is so much not
known in science. There are clues not found yet. Researchers make the connections no one has
made yet.
My mentor has been working on our project in bits and pieces for over seven years.
When he participates in undergraduate fellowship research he has the funds to work on the
project. It takes time and motivation to not give up. Research also takes creativity. Some
people think it is easy to classify someone as an artsy or scientific, type A or type B personality,
cluttered or organized; however, a scientist needs both. Scientists must be organized and
meticulous, but they also have to be creative. Research is not about reproducing someone else's
work. It is about taking someone else's findings, combining them with your current knowledge
and creating a unique experiment to demonstrate your ideas or hypothesis of what may happen.
Researchers also have to be aware of their audience, as in the organizations which fund the
projects and give the grants. Researchers have to make sure they are researching something
which will be of interest to the organizations and appeal to them, because researchers need their
projects to be selected in order to have money to support their research.
I conducted research the summer of 2013 at DAMS in Dr. Liu 's lab. In the fall of 2014, I
will be attending UAMS College of Pharmacy. My whole thesis has been fueled by my respect
for research and appreciation for my experience, but I myself am not pursuing a career in
research. Please do not think in any way that my thesis is hypocritical or insincere because I am
not pursuing that career path myself. That summer has shown me a new insight into research,
allowed me to make new friends, expand my network, go on field trips to places I would not
have been able to attend before, present at conferences, and travel. I am thankful. I am honored

and truly enjoy presenting my work and get excited to share the good news of my results. I
would consider research as a summer job because research can be relaxing at times when the
work and tests conducted become a habit; however, they can also become very repetitive and I
desire some variety in my future career.
I am still in contact with Dr. Liu and send him updates in relation to pharmacy school and
presentations. I will see Dr. Liu again- many times, actually. He will be one of my pharmacy
teachers at DAMS. I may not learn anything about the tree bark of Terminalia arjuna in his
class, but I know I will be learning. That's what life is: we learn, we grow, we make mistakes,
we want redos, we practice learning, we practice speaking, we practice new skills and we will
eventually make progress. So, no matter what specific area of pharmacy, science or life I find
myself in, as long as I keep moving forward and keep learning I am making progress and making
a difference. That is what research taught to me to do with my life: make a difference. If we can
each do that with our own lives, we will each be a success.

